Ардзинба Мераб Сергеевич
Russian Cancer Research Center NN Blokhin · 33 works · 18 citations · h-index 3
Top works
- P3.02a-031 Non-Small Cell Lung Cancer Targeted Therapy in Case of ROS1 Rearrangement
- Prospects for the development of adjuvant therapy for non-small cell lung cancer
- Pseudoprogression in patients on immunotherapy
- A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer
- First results of durvalumab after chemoradiotherapy in locally advanced non-small-cell lung cancer in Russia
- Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature
- Rational approach to the treatment of EGFR-positive lung cancer
- Efficiency integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer and an activating EGFR gene mutation.
- Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
- Conservative treatment of stage III lung cancer using chemoradiotherapy in hypofractionation mode, case report
- Повторная биопсия у больных немелкоклеточным раком легкого IV стадии после лекарственного лечения
- Приобретенная резистентность к ингибиторам тирозинкиназы egfr: пути преодоления
- Rebiopsy in IV stage non-small-cell lung cancer patients after systemic therapy
- HIGH-TECH RADIATION THERAPY WITH LOCAL DOSE ESCALATION IN CHEMO-RADIATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER. PREDICTORS OF EFFECTIVENESS
- Предикторы непосредственной эффективности неоадъювантной иммунохимиотерапии у больных операбельными формами немелкоклеточного рака легкого. Данные реальной клинической практики НМИЦ онкологии им. Н.Н. Блохина
- РАЦИОНАЛЬНЫЙ ПОДХОД К ТЕРАПИИ EGFR-ПОЗИТИВНОГО РАКА ЛЕГКОГО
- TARGETED THERAPY OF NON-SMALL-CELL LUNG CANCER PATIENTS: MOST COMMON ADVERSE EVENTS AND METHODS OF THEIR CORRECTIONS
- СТАНЕТ ЛИ НЕОАДЪЮВАНТНАЯ ИММУНОТЕРАПИЯ НОВОЙ ПАРАДИГМОЙ ЛЕЧЕНИЯ БОЛЬНЫХ РАКОМ ЛЕГКОГО
- Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients
- Abscopal effect in a patient with metastatic NSCLC following a course of radiation therapy to the brain